APA (7th ed.) Citation

Narkiewicz, K., Prejbisz, A., Januszewicz, A., Lewandowska, K., Lipski, D., Uruski, P., . . . Tykarski, A. Randomised, double-blind, placebo-controlled study evaluating the effect of allopurinol on the risk of cardiovascular events in patients with high and very high cardiovascular risk, including the presence of long-COVID-19 syndrome: The ALL-VASCOR study protocol. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Narkiewicz, Krzysztof, et al. Randomised, Double-blind, Placebo-controlled Study Evaluating the Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with High and Very High Cardiovascular Risk, Including the Presence of Long-COVID-19 Syndrome: The ALL-VASCOR Study Protocol. BMJ Publishing Group.

MLA (9th ed.) Citation

Narkiewicz, Krzysztof, et al. Randomised, Double-blind, Placebo-controlled Study Evaluating the Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with High and Very High Cardiovascular Risk, Including the Presence of Long-COVID-19 Syndrome: The ALL-VASCOR Study Protocol. BMJ Publishing Group.